The DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.
Thermal and mechanical high-intensity focused ultrasound: perspectives on tumor ablation, immune effects and combination strategies
Open accessAbstract
Tumor ablation technologies, such as radiofrequency-, cryo- or high-intensity focused ultrasound (HIFU) ablation will destroy tumor tissue in a minimally invasive manner. Ablation generates large volumes of tumor debris in situ, releasing multiple bio-molecules like tumor antigens and damage-associated molecular patterns. To initiate an adaptive antitumor immune response, antigen-presenting cells need to take up tumor antigens and, following activation, present them to immune effector cells. The impact of the type of tumor ablation on the precise nature, availability and suitability of the tumor debris for immune response induction, however, is poorly understood. In this review, we focus on immune effects after HIFU-mediated ablation and compare these to findings using other ablation technologies. HIFU can be used both for thermal and mechanical destruction of tissue, inducing coagulative necrosis or subcellular fragmentation, respectively. Preclinical and clinical results of HIFU tumor ablation show increased infiltration and activation of CD4 + and CD8 + T cells. As previously observed for other types of tumor ablation technologies, however, this ablation-induced enhanced infiltration alone appears insufficient to generate consistent protective antitumor immunity. Therapies combining ablation with immune stimulation are therefore expected to be key to boost HIFU-induced immune effects and to achieve systemic, long-lasting, antitumor immunity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Akira, S., & Takeda, K. (2004) · Nature reviews. Immunology · doi:10.1038/nri1391 · Cited by 8,312
Vogelstein, B., Papadopoulos, N., Velculescu, V. E., Zhou, S., Diaz, L. A., & Kinzler, K. W. (2013) · Science · doi:10.1126/science.1235122 · Cited by 7,863
Clonal neoantigens elicit T cell immunoreactivity and sensitivity to immune checkpoint blockade
McGranahan, N., Furness, A. J. S., Rosenthal, R., Ramskov, S., Lyngaa, R., Saini, S. K., Jamal-Hanjani, M., Wilson, G. A., Birkbak, N. J., Hiley, C. T., et al. (2016) · Science · doi:10.1126/science.aaf1490 · Cited by 3,065
Immune checkpoint targeting in cancer therapy: toward combination strategies with curative potential
Sharma, P., & Allison, J. P. (2015) · Cell · doi:10.1016/j.cell.2015.03.030 · Cited by 2,345
Nucleotides released by apoptotic cells act as a find-me signal to promote phagocytic clearance
Elliott, M. R., Chekeni, F. B., Trampont, P. C., Lazarowski, E. R., Kadl, A., Walk, S. F., Park, D., Woodson, R. I., Ostankovich, M., Sharma, P., et al. (2009) · Nature · doi:10.1038/nature08296 · Cited by 1,654
Cancer exome analysis reveals a T-cell-dependent mechanism of cancer immunoediting
Matsushita, H., Vesely, M. D., Koboldt, D. C., Rickert, C. G., Uppaluri, R., Magrini, V. J., Arthur, C. D., White, J. M., Chen, Y.-S., Shea, L. K., et al. (2012) · Nature · doi:10.1038/nature10755 · Cited by 1,288
High-intensity focused ultrasound in the treatment of solid tumours
Kennedy, J. E. (2005) · Nature Reviews Cancer · doi:10.1038/nrc1591 · Cited by 1,282
Radiation-induced bystander signalling in cancer therapy
Prise, K. M., & O'Sullivan, J. M. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2603 · Cited by 810
Exploiting the Mutanome for Tumor Vaccination
Castle, J. C., Kreiter, S., Diekmann, J., Löwer, M., van de Roemer, N., de Graaf, J., Selmi, A., Diken, M., Boegel, S., Paret, C., et al. (2012) · Cancer Research · doi:10.1158/0008-5472.can-11-3722 · Cited by 810
Radiotherapy and Immunogenic Cell Death
Golden, E. B., & Apetoh, L. (2015) · Seminars in Radiation Oncology · doi:10.1016/j.semradonc.2014.07.005 · Cited by 463
In Situ Tumor Ablation Creates an Antigen Source for the Generation of Antitumor Immunity
den Brok, M. H. M. G. M., Sutmuller, R. P. M., van der Voort, R., Bennink, E. J., Figdor, C. G., Ruers, T. J. M., & Adema, G. J. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-3949 · Cited by 426
Self-citationMRI-Guided Focused Ultrasound Surgery
Jolesz, F. A. (2009) · Annual Review of Medicine · doi:10.1146/annurev.med.60.041707.170303 · Cited by 377
Roberts, W. W., Hall, T. L., Ives, K., Wolf, J. S., Fowlkes, J. B., & Cain, C. A. (2006) · Journal of Urology · doi:10.1016/s0022-5347(05)00141-2 · Cited by 362
Cavitation clouds created by shock scattering from bubbles during histotripsy
Maxwell, A. D., Wang, T.-Y., Cain, C. A., Fowlkes, J. B., Sapozhnikov, O. A., Bailey, M. R., & Xu, Z. (2011) · The Journal of the Acoustical Society of America · doi:10.1121/1.3625239 · Cited by 317
Histotripsy methods in mechanical disintegration of tissue: Towards clinical applications
Khokhlova, V. A., Fowlkes, J. B., Roberts, W. W., Schade, G. R., Xu, Z., Khokhlova, T. D., Hall, T. L., Maxwell, A. D., Wang, Y.-N., & Cain, C. A. (2015) · International Journal of Hyperthermia · doi:10.3109/02656736.2015.1007538 · Cited by 317
Wu, F., Wang, Z.-B., Chen, W.-Z., Wang, W., Gui, Y., Zhang, M., Zheng, G., Zhou, Y., Xu, G., Li, M., et al. (2004) · Ultrasonics Sonochemistry · doi:10.1016/j.ultsonch.2004.01.011 · Cited by 313
PD-1 Blockade Boosts Radiofrequency Ablation–Elicited Adaptive Immune Responses against Tumor
Shi, L., Chen, L., Wu, C., Zhu, Y., Xu, B., Zheng, X., Sun, M., Wen, W., Dai, X., Yang, M., et al. (2016) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-15-1352 · Cited by 312
Immunogenic cancer cell death: a key-lock paradigm
Tesniere, A., Apetoh, L., Ghiringhelli, F., Joza, N., Panaretakis, T., Kepp, O., Schlemmer, F., Zitvogel, L., & Kroemer, G. (2008) · Current Opinion in Immunology · doi:10.1016/j.coi.2008.05.007 · Cited by 307
den Brok, M. H. M. G. M., Sutmuller, R. P. M., Nierkens, S., Bennink, E. J., Frielink, C., Toonen, L. W. J., Boerman, O. C., Figdor, C. G., Ruers, T. J. M., & Adema, G. J. (2006) · British Journal of Cancer · doi:10.1038/sj.bjc.6603341 · Cited by 296
Self-citationCancer Immunotherapy and Breaking Immune Tolerance: New Approaches to an Old Challenge
Makkouk, A., & Weiner, G. J. (2015) · Cancer Research · doi:10.1158/0008-5472.can-14-2538 · Cited by 285
Potent Induction of Tumor Immunity by Combining Tumor Cryoablation with Anti–CTLA-4 Therapy
Waitz, R., Solomon, S. B., Petre, E. N., Trumble, A. E., Fassò, M., Norton, L., & Allison, J. P. (2012) · Cancer Research · doi:10.1158/0008-5472.can-11-1782 · Cited by 282
Wu, F., Wang, Z.-B., Chen, W.-Z., Zhu, H., Bai, J., Zou, J.-Z., Li, K.-Q., Jin, C.-B., Xie, F.-L., & Su, H.-B. (2004) · Annals of Surgical Oncology · doi:10.1245/aso.2004.02.026 · Cited by 278
More Than Just Tumor Destruction: Immunomodulation by Thermal Ablation of Cancer
Haen, S. P., Pereira, P. L., Salih, H. R., Rammensee, H.-G., & Gouttefangeas, C. (2011) · Clinical and Developmental Immunology · doi:10.1155/2011/160250 · Cited by 233
Canney, M. S., Khokhlova, V. A., Bessonova, O. V., Bailey, M. R., & Crum, L. A. (2009) · Ultrasound in Medicine & Biology · doi:10.1016/j.ultrasmedbio.2009.09.010 · Cited by 228
Investigation of HIFU-induced anti-tumor immunity in a murine tumor model
Hu, Z., Yang, X. Y., Liu, Y., Sankin, G. N., Pua, E. C., Morse, M. A., Lyerly, H. K., Clay, T. M., & Zhong, P. (2007) · Journal of Translational Medicine · doi:10.1186/1479-5876-5-34 · Cited by 209
Soanes, W. A., Ablin, R. J., & Gonder, M. J. (1970) · Journal of Urology · doi:10.1016/s0022-5347(17)61690-2 · Cited by 205
den Brok, M. H. M. G. M., Sutmuller, R. P. M., Nierkens, S., Bennink, E. J., Toonen, L. W. J., Figdor, C. G., Ruers, T. J. M., & Adema, G. J. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-0206 · Cited by 176
Self-citationActivated anti-tumor immunity in cancer patients after high intensity focused ultrasound ablation
Wu, F., Wang, Z.-B., Lu, P., Xu, Z.-L., Chen, W.-Z., Zhu, H., & Jin, C.-B. (2004) · Ultrasound in Medicine & Biology · doi:10.1016/j.ultrasmedbio.2004.08.003 · Cited by 171
Erinjeri, J. P., Thomas, C. T., Samoilia, A., Fleisher, M., Gönen, M., Sofocleous, C. T., Thornton, R. H., Siegelbaum, R. H., Covey, A. M., Brody, L. A., et al. (2013) · Journal of Vascular and Interventional Radiology · doi:10.1016/j.jvir.2013.02.015 · Cited by 154
Lu, P., Zhu, X., Xu, Z.-L., Zhou, Q., Zhang, J., & Wu, F. (2009) · Surgery · doi:10.1016/j.surg.2008.10.010 · Cited by 124
Hu, Z., Yang, X. Y., Liu, Y., Morse, M. A., Lyerly, H. K., Clay, T. M., & Zhong, P. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.07.071 · Cited by 120
Merckel, L. G., Knuttel, F. M., Deckers, R., van Dalen, T., Schubert, G., Peters, N. H. G. M., Weits, T., van Diest, P. J., Mali, W. P. T. M., Vaessen, P. H. B., et al. (2016) · European Radiology · doi:10.1007/s00330-016-4222-9 · Cited by 117
Nierkens, S., den Brok, M. H., Garcia, Z., Togher, S., Wagenaars, J. A. L., Wassink, M., Boon, L., Ruers, T. J. M., Figdor, C. G., Schoenberger, S. P., et al. (2011) · Cancer Research · doi:10.1158/0008-5472.can-11-2154 · Cited by 114
Self-citationNierkens, S., den Brok, M. H., Roelofsen, T., Wagenaars, J. A. L., Figdor, C. G., Ruers, T. J. M., & Adema, G. J. (2009) · PLoS ONE · doi:10.1371/journal.pone.0008368 · Cited by 95
Self-citationHLA ligandome tumor antigen discovery for personalized vaccine approach
Rammensee, H., & Singh‐Jasuja, H. (2013) · Expert Review of Vaccines · doi:10.1586/14760584.2013.836911 · Cited by 92
Kramer, G., Steiner, G., Gröbl, M., Hrachowitz, K., Reithmayr, F., Paucz, L., Newman, M., Madersbacher, S., Gruber, D., Susani, M., et al. (2003) · The Prostate · doi:10.1002/pros.10314 · Cited by 81
Xu, Z.-L., Zhu, X., Lu, P., Zhou, Q., Zhang, J., & Wu, F. (2008) · Ultrasound in Medicine & Biology · doi:10.1016/j.ultrasmedbio.2008.08.005 · Cited by 81
Liu, F., Hu, Z., Qiu, L., Hui, C., Li, C., Zhong, P., & Zhang, J. (2010) · Journal of Translational Medicine · doi:10.1186/1479-5876-8-7 · Cited by 75
Zhou, Q., Zhu, X., Zhang, J., Xu, Z.-L., Lu, P., & Wu, F. (2007) · Ultrasound in Medicine & Biology · doi:10.1016/j.ultrasmedbio.2007.07.013 · Cited by 74
Deng, J., Zhang, Y., Feng, J., & Wu, F. (2010) · Ultrasound in Medicine & Biology · doi:10.1016/j.ultrasmedbio.2009.12.004 · Cited by 70
Huang, X., Yuan, F., Liang, M., Lo, H., Shinohara, M. L., Robertson, C. N., & Zhong, P. (2012) · PLoS ONE · doi:10.1371/journal.pone.0041632 · Cited by 67
Elevated serum levels of heat shock protein 70 can be detected after radiofrequency ablation
Haen, S. P., Gouttefangeas, C., Schmidt, D., Boss, A., Clasen, S., von Herbay, A., Kosan, B., Aebert, H., Pereira, P. L., & Rammensee, H. (2011) · Cell Stress and Chaperones · doi:10.1007/s12192-011-0261-y · Cited by 67
Liu, Q., Zhai, B., Yang, W., Yu, L., Dong, W., He, Y., Chen, L., Tang, L., Lin, Y., Huang, D., et al. (2009) · Molecular Therapy · doi:10.1038/mt.2009.221 · Cited by 56
Changes in biologic characteristics of breast cancer treated with high-intensity focused ultrasound
Wu, F., Wang, Z., Cao, Y., Chen, W., Zou, J., Bai, J., Zhu, H., Li, K., Jin, C., Xie, F.-L., et al. (2003) · Ultrasound in Medicine & Biology · doi:10.1016/s0301-5629(03)01034-2 · Cited by 51
Ito, F., Ku, A. W., Bucsek, M. J., Muhitch, J. B., Vardam-Kaur, T., Kim, M., Fisher, D. T., Camoriano, M., Khoury, T., Skitzki, J. J., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0143370 · Cited by 43
den Brok, M. H., Nierkens, S., Wagenaars, J. A. L., Ruers, T. J. M., Schrier, C. C., Rijke, E., & Adema, G. J. (2011) · Vaccine · doi:10.1016/j.vaccine.2011.11.080 · Cited by 40
Self-citationAlteber, Z., Azulay, M., Cafri, G., Vadai, E., Tzehoval, E., & Eisenbach, L. (2014) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-014-1520-4 · Cited by 35
Chida, S., Okada, K., Suzuki, N., Komori, C., & Shimada, Y. (2009) · PubMed · Cited by 17
Radiofrequency Ablation in Cancer Therapy: Tuning in to in situ Tumor Vaccines
Nierkens, S., den Brok, M. H., Ruers, T. J. M., & Adema, G. J. (2012) · Springer eBooks · doi:10.1007/978-94-007-4694-7_3 · Cited by 7
Self-citation
Cited by
Nanoparticle-assisted ultrasound: A special focus on sonodynamic therapy against cancer
Canavese, G., Ancona, A., Racca, L., Canta, M., Dumontel, B., Barbaresco, F., Limongi, T., & Cauda, V. (2018) · Chemical Engineering Journal · doi:10.1016/j.cej.2018.01.060 · Cited by 457
High intensity focused ultrasound: The fundamentals, clinical applications and research trends
Elhelf, I. A. S., Albahar, H., Shah, U., Oto, A., Cressman, E., & Almekkawy, M. (2018) · Diagnostic and Interventional Imaging · doi:10.1016/j.diii.2018.03.001 · Cited by 264
Activating Drugs with Sound: Mechanisms Behind Sonodynamic Therapy and the Role of Nanomedicine
Choi, V., Rajora, M. A., & Zheng, G. (2020) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.0c00029 · Cited by 237
Ultrasound-induced immune responses in tumors: A systematic review and meta-analysis
Rix, A., Heinrichs, H., Porte, C., Leenaars, C., Bleich, A., & Kiessling, F. (2024) · Journal of Controlled Release · doi:10.1016/j.jconrel.2024.05.030 · Cited by 21
Kang, Z., Yang, M., Feng, X., Liao, H., Zhang, Z., & Du, Y. (2022) · International Journal of Nanomedicine · doi:10.2147/ijn.s360161 · Cited by 21
Metadata
- Authors
- van den Bijgaart, R. J. E., Eikelenboom, D. C., Hoogenboom, M., Fütterer, J. J., den Brok, M. H., & Adema, G. J.
- Venue
- Cancer Immunology, Immunotherapy
- Published
- 2016-09-01
- Volume
- 66
- Issue
- 2
- Pages
- 247-258
- ISSN
- 0340-7004 (ISSN-L)
- 1432-0851
- OpenAlex
- W2510683324
- Cited by
- 276
- References
- 49
- FWCI
- 8.51
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.